Unraveling the Dual Immunomodulatory and Immunogenic Roles of the Central Conserved Cysteine-Rich Region in Respiratory Syncytial Virus G Protein
Gutman, J.; Paletta, A.; Birnberg-Weiss, F.; Prato, A.; Boudgouste, A.; Goldin, C. J.; Sastre, S.; Byrne, A.; Pakciarz, P.; Polack, F. P.; Dvorkin, J.; Zeida, A.; Caballero, M.; Fernandez, G.; Tribulatti, V.; Alvarez-Paggi, D.; Esperante, S.
Show abstract
Respiratory syncytial virus (RSV) causes severe respiratory disease in infants and high-risk adults, in part by subverting host immunity. The RSV G glycoproteins central conserved cysteine-rich domain (CCD) contains a CX3C motif implicated in immune modulation, but the relationship between CCD redox state, structure and function is unresolved. We recombinantly expressed a CCD peptide (Gpep, residues 149-196) and combined structural and biophysical characterizations with cellular immunology and human serology to define how redox-dependent conformations govern immunogenicity and immunomodulation. Reduced Gpep is compact and rapidly folds via a dominant intermediate into an oxidized, extended monomer; at higher concentrations intermolecular disulfide isomerization produces covalent oligomers. Functionally, monomeric Gpep potently suppresses innate and adaptive activation inhibiting LPS- or UV-inactivated RSV-induced maturation of mouse bone marrow-derived dendritic cells, reducing antigen-specific CD4+ T cell proliferation and IFN-{gamma} production, and attenuating multiple human neutrophil responses (chemotaxis, CD11b upregulation, ROS, MPO release and NET formation), without cytotoxicity. Oligomerized Gpep lacks these suppressive activities. To link molecular mechanism and human exposure, analysis of sera from an ambulatory pediatric cohort (0-72 months) showed a progressive transient increase in the anti-F/anti-G IgG ratio with repeated early RSV exposures, maturating into a functional 2 to 3 ratio. This serologic shift is consistent with previously reported enrichment of F-directed neutralizing immunity. We propose a redox-dependent immune-evasion model in which soluble, monomeric G mediates transient immunosuppression that is removed by disulfide-driven oligomerization, which may occur in membrane-bound G. This may impact therapeutic strategies that commonly favor F-focused responses. ImportanceRespiratory syncytial virus (RSV) remains a leading cause of severe respiratory disease in young children and high-risk adults. This study identifies a chemical switch in a small conserved region of the RSV attachment protein that changes its shape and immune activity: when the region is present as a soluble, single chain, it transiently suppresses key innate and adaptive immune cells, but this activity is lost upon disulfide-mediated oligomerization. We also show that repetitive RSV exposures in early life bias the antibody response, initially boosting antibody responses toward the Fusion protein, rather than this conserved central region. Together, these results may uncover a mechanism by which RSV shapes the host immune response explaining the features of antibody development in children. Understanding this redox-dependent balance between immune evasion and antigenicity will inform safer vaccine and antibody strategies against RSV.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins 96%
- In silico design of Phl p 6 variants with altered folding stability significantly impacts antigen processing, immunogenicity and immune polarization 94%
- Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant. 94%
Similar papers in this journal
- Tetravalent SARS-CoV-2 S1 Subunit Protein Vaccination Elicits Robust Humoral and Cellular Immune Responses in SIV-Infected Rhesus Macaque Controllers 94%
- GP96 drives exacerbation of secondary bacterial pneumonia following influenza A virus infection 94%
- A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseases 94%
Similar papers in this journal
- Preclinical establishment of a divalent vaccine against SARS-CoV-2 95%
- Cell-free screening, production and animal testing of a STI-related chlamydial major outer membrane protein supported in nanolipoproteins. 94%
- A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model 94%
Similar papers in this journal
- Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli (STEC). 94%
- Enhanced protective efficacy of a novel, thermostable, RBD-S2 fusion immunogen against SARS-CoV-2 and its variants 94%
- One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects non-human primates from SARS-CoV-2 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.